Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study data

Katy J L Bell, Elaine Beller, Johan Sundström, Kevin McGeechan, Andrew Hayen, Les Irwig, Bruce Neal, Paul Glasziou

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)
17 Downloads (Pure)

Abstract

Objective: To determine the incremental value of ambulatory blood pressure (BP) in predicting cardiovascular risk when the Framingham Risk Score (FRS) is known. Methods: We included 780 men without cardiovascular disease from the Uppsala Longitudinal Study of Adult Men, all aged approximately 70 years at baseline. We first screened ambulatory systolic BP (ASBP) parameters for their incremental value by adding them to a model with 10-year FRS. For the best ASBP parameter we estimated HRs and changes in discrimination, calibration and reclassification. We also estimated the difference in the number of men started on treatment and in the number of men protected against a cardiovascular event. Results: Mean daytime ASBP had the highest incremental value; adding other parameters did not yield further improvements. While ASBP was an independent risk factor for cardiovascular disease, addition to FRS led to only small increases to the overall model fit, discrimination (a 1% increase in the area under the receiver operating characteristic (ROC) curve), calibration and reclassification. We estimated that for every 10 000 men screened with ASBP, 141 fewer would start a new BP-lowering treatment (95% CI 62 to 220 less treated), but this would result in 7 fewer cardiovascular events prevented over the subsequent 10 years (95% CI 21 fewer events prevented to 7 more events prevented). Conclusions: In addition to a standard cardiovascular risk assessment it is not clear that ambulatory BP measurement provides further incremental value. The clinical role of ambulatory BP requires ongoing careful consideration.

Original languageEnglish
Article numbere006044
JournalBMJ Open
Volume4
DOIs
Publication statusPublished - 2014

Fingerprint

Primary Prevention
Observational Studies
Cardiovascular Diseases
Blood Pressure
Calibration
ROC Curve
Longitudinal Studies
Therapeutics

Cite this

@article{9f66664f0e4e4603a7845a8d11e08bc1,
title = "Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study data",
abstract = "Objective: To determine the incremental value of ambulatory blood pressure (BP) in predicting cardiovascular risk when the Framingham Risk Score (FRS) is known. Methods: We included 780 men without cardiovascular disease from the Uppsala Longitudinal Study of Adult Men, all aged approximately 70 years at baseline. We first screened ambulatory systolic BP (ASBP) parameters for their incremental value by adding them to a model with 10-year FRS. For the best ASBP parameter we estimated HRs and changes in discrimination, calibration and reclassification. We also estimated the difference in the number of men started on treatment and in the number of men protected against a cardiovascular event. Results: Mean daytime ASBP had the highest incremental value; adding other parameters did not yield further improvements. While ASBP was an independent risk factor for cardiovascular disease, addition to FRS led to only small increases to the overall model fit, discrimination (a 1{\%} increase in the area under the receiver operating characteristic (ROC) curve), calibration and reclassification. We estimated that for every 10 000 men screened with ASBP, 141 fewer would start a new BP-lowering treatment (95{\%} CI 62 to 220 less treated), but this would result in 7 fewer cardiovascular events prevented over the subsequent 10 years (95{\%} CI 21 fewer events prevented to 7 more events prevented). Conclusions: In addition to a standard cardiovascular risk assessment it is not clear that ambulatory BP measurement provides further incremental value. The clinical role of ambulatory BP requires ongoing careful consideration.",
author = "Bell, {Katy J L} and Elaine Beller and Johan Sundstr{\"o}m and Kevin McGeechan and Andrew Hayen and Les Irwig and Bruce Neal and Paul Glasziou",
year = "2014",
doi = "10.1136/bmjopen-2014-006044",
language = "English",
volume = "4",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group",

}

Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men : Secondary analysis of observational study data. / Bell, Katy J L; Beller, Elaine; Sundström, Johan; McGeechan, Kevin; Hayen, Andrew; Irwig, Les; Neal, Bruce; Glasziou, Paul.

In: BMJ Open, Vol. 4, e006044, 2014.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men

T2 - Secondary analysis of observational study data

AU - Bell, Katy J L

AU - Beller, Elaine

AU - Sundström, Johan

AU - McGeechan, Kevin

AU - Hayen, Andrew

AU - Irwig, Les

AU - Neal, Bruce

AU - Glasziou, Paul

PY - 2014

Y1 - 2014

N2 - Objective: To determine the incremental value of ambulatory blood pressure (BP) in predicting cardiovascular risk when the Framingham Risk Score (FRS) is known. Methods: We included 780 men without cardiovascular disease from the Uppsala Longitudinal Study of Adult Men, all aged approximately 70 years at baseline. We first screened ambulatory systolic BP (ASBP) parameters for their incremental value by adding them to a model with 10-year FRS. For the best ASBP parameter we estimated HRs and changes in discrimination, calibration and reclassification. We also estimated the difference in the number of men started on treatment and in the number of men protected against a cardiovascular event. Results: Mean daytime ASBP had the highest incremental value; adding other parameters did not yield further improvements. While ASBP was an independent risk factor for cardiovascular disease, addition to FRS led to only small increases to the overall model fit, discrimination (a 1% increase in the area under the receiver operating characteristic (ROC) curve), calibration and reclassification. We estimated that for every 10 000 men screened with ASBP, 141 fewer would start a new BP-lowering treatment (95% CI 62 to 220 less treated), but this would result in 7 fewer cardiovascular events prevented over the subsequent 10 years (95% CI 21 fewer events prevented to 7 more events prevented). Conclusions: In addition to a standard cardiovascular risk assessment it is not clear that ambulatory BP measurement provides further incremental value. The clinical role of ambulatory BP requires ongoing careful consideration.

AB - Objective: To determine the incremental value of ambulatory blood pressure (BP) in predicting cardiovascular risk when the Framingham Risk Score (FRS) is known. Methods: We included 780 men without cardiovascular disease from the Uppsala Longitudinal Study of Adult Men, all aged approximately 70 years at baseline. We first screened ambulatory systolic BP (ASBP) parameters for their incremental value by adding them to a model with 10-year FRS. For the best ASBP parameter we estimated HRs and changes in discrimination, calibration and reclassification. We also estimated the difference in the number of men started on treatment and in the number of men protected against a cardiovascular event. Results: Mean daytime ASBP had the highest incremental value; adding other parameters did not yield further improvements. While ASBP was an independent risk factor for cardiovascular disease, addition to FRS led to only small increases to the overall model fit, discrimination (a 1% increase in the area under the receiver operating characteristic (ROC) curve), calibration and reclassification. We estimated that for every 10 000 men screened with ASBP, 141 fewer would start a new BP-lowering treatment (95% CI 62 to 220 less treated), but this would result in 7 fewer cardiovascular events prevented over the subsequent 10 years (95% CI 21 fewer events prevented to 7 more events prevented). Conclusions: In addition to a standard cardiovascular risk assessment it is not clear that ambulatory BP measurement provides further incremental value. The clinical role of ambulatory BP requires ongoing careful consideration.

UR - http://www.scopus.com/inward/record.url?scp=84910608449&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2014-006044

DO - 10.1136/bmjopen-2014-006044

M3 - Article

VL - 4

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

M1 - e006044

ER -